Maximizing the Value of Your Drug Development Program

This session will discuss current changes in the laboratory testing marketplace and the impact on healthcare. Major trends will be discussed specific to physician practice, reimbursement, government programs, and patient care. Opportunities for clinical laboratories and pathology groups to add value for patients, physicians, payers, and hospitals will be examined. Discuss the basic forces for change present in the national marketplace for clinical laboratory and anatomic pathology testing. Explain the ways basic forces may disrupt existing relationships between laboratories and providers. Highlight management approaches to enable clinical laboratories to deliver high-value testing services to integrated healthcare organizations.

M&IW’s HMCC-certified buyers recently attended Pharma Forum and picked up the latest and greatest tips on sourcing healthcare meetings. In our next See the Impossible Webinar Series, learn how transparency, accountability and creative thinking can alleviate unnecessary back and forth and streamline the hotel procurement process.

Poorly soluble drugs for oral administration present unique formulation challenges, particularly during early development. Formulation in a lipid-based carrier can be a feasible approach, but usually requires extensive testing to find suitable excipient combination.

The frontiers of data sciences and real-world data represent promising areas of innovation and possibility for life sciences and health-care organizations, especially within precision medicine. These areas are continuously evolving, and there are questions about how to navigate this complex and rapidly evolving set of resources, capabilities, and organizations. This webinar, in partnership with the Kraft Precision Medicine Accelerator at the Harvard Business School, aims to provide a landscape of the organizations working in real-world data and advanced analytics, including artificial intelligence and machine learning, and provide commentary on the recent changes to space. It will introduce attendees to the Kraft Precision Medicine Accelerator and teach them about real-world data analytics technologies and data assets that may help advance their research agendas, determine the subject of collaborations, or serve as an investment target.